Related Experiment Video
Updated: May 11, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Potential causal association between gut microbiota, inflammatory cytokines, and acute pancreatitis: A Mendelian
Xiaofeng Wang1,2, Yiwen Qiu3, Ying Di4
1Department of Critical Care Medicine, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Background:
Acute pancreatitis (AP) ranks among the most frequently encountered gastrointestinal diseases in the emergency department. Recent studies have increasingly emphasized the substantial connection among gut microbiota, inflammatory cytokines, and AP.
Methods:
A two-sample Mendelian randomization (MR) study was conducted using summary statistics of gut microbiota (GM) from the largest available meta-analysis of genome-wide association studies conducted by the MiBioGen consortium (n=18,340). For cytokines, the data were obtained from a study that investigated genome variant associations with 41 inflammatory cytokines and growth factors (n=8293). The summary statistics of AP were obtained from the FinnGen consortium version R5 data (3022 cases and 195,144 controls). The inverse variance weighted (IVW) method was used as the main analysis, with MR-Egger and weighted median as complementary analytical methods. Sensitivity analyses were performed using Cochran's Q-test, MR-Egger intercept test, leave-one-out analyses, and MR-PRESSO. In addition, we employed the reverse MR analysis and MR Steiger method to estimate the orientations of exposure and outcome.
Result:
Among the 211 examined GM taxa, the IVW method revealed that Bacteroidales (odds ratio [OR]=1.412, 95% confidence interval [CI]:1.057 to 1.885, P=0.019), Eubacterium fissicatena group (OR=1.240, 95% CI:1.045 to 1.470, P=0.014), and Coprococcus3 (OR=1.481, 95 % CI:1.049 to 2.090, P=0.026) exhibited a positive association with AP. Conversely, Prevotella9 (OR=0.821, 95% CI:0.680 to 0.990, P=0.038), RuminococcaceaeUCG004 (OR=0.757, 95% CI:0.577 to 0.994, P=0.045), and Ruminiclostridium6 (OR=0.696, 95% CI:0.548 to 0.884, P=0.003) displayed a negative correlation with AP. Among the 41 inflammatory cytokines, only macrophage colony-stimulating factor (M_CSF, OR=0.894, 95% CI:0.847 to 0.943, P=0.037) exhibited a negative association with AP. Sensitivity analyses revealed no evidence of pleiotropy or heterogeneity. Nevertheless, the mediation analysis showed that M_CSF did not act as a mediating factor.
Conclusion:
This two-sample MR study revealed causal associations between specific GM and inflammatory cytokines with AP, respectively. However, inflammatory cytokines did not appear to act as mediating factors in the pathway from GM to AP.
Insights
This study found specific gut bacteria linked to acute pancreatitis (AP) risk. While some bacteria increase AP risk, others decrease it, but inflammatory cytokines don't mediate this connection.
Area of Science:
- Gastroenterology
- Genetics
- Microbiome Research
Background:
- Acute pancreatitis (AP) is a common gastrointestinal emergency.
- Emerging evidence highlights the interplay between gut microbiota (GM), inflammatory cytokines, and AP development.
Purpose of the Study:
- To investigate the potential causal relationships between gut microbiota, inflammatory cytokines, and acute pancreatitis using Mendelian randomization.
- To explore the mediating role of inflammatory cytokines in the gut microbiota-AP axis.
Main Methods:
- A two-sample Mendelian randomization (MR) study utilized summary statistics for GM (n=18,340), cytokines (n=8293), and AP (3022 cases, 195,144 controls).
- Inverse variance weighted (IVW) method was primary, with MR-Egger and weighted median as sensitivity analyses.
- Sensitivity analyses included Cochran's Q-test, MR-Egger intercept, leave-one-out, and MR-PRESSO to assess pleiotropy and heterogeneity.
Main Results:
- Several GM taxa showed significant associations with AP risk: Bacteroidales, Eubacterium fissicatena group, and Coprococcus3 were positively associated, while Prevotella9, RuminococcaceaeUCG004, and Ruminiclostridium6 were negatively associated.
- Macrophage colony-stimulating factor (M-CSF) was the only cytokine negatively associated with AP.
- Mediation analysis indicated M-CSF did not mediate the relationship between GM and AP.
Conclusions:
- Specific gut microbiota compositions are causally associated with acute pancreatitis risk.
- While M-CSF shows an inverse association with AP, it does not mediate the effects of gut microbiota on AP development.
More Related Videos
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Acute Pancreatitis II: Clinical Manifestations and Management
What is Monogastric Digestion?